In July, Goldman Sachs Group Inc. (NYSE: GS ) and Morgan Stanley (NYSE: MS ) said they were preparing to arrange more than $6.5 billion (6 billion euros) in debt financing for potential buyers interested in acquiring Sanofi's consumer health division.